Clinical Trial Update: Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma [Phase 2]

View source ↗

Summary

A Phase 2 trial of Paxalisib in glioblastoma, evaluating a high-fat, low-carb diet with metformin, has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Paxalisib (GDC-0084)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Glioblastoma | Phase 2 | Status: SUSPENDED